The first National Cancer Center Radiation Tumor Therapy Academic Conference was held in Beijing from June 21st to 22nd. The conference was hosted by the National Cancer Center and the Beijing Society of Oncology, and organized by the Cancer Hospital of the Chinese Academy of Medical Sciences. Top experts in the field of cancer treatment at home and abroad discussed in depth the cutting-edge technology and clinical practice of precision radiotherapy around the concept of "integration, innovation, and win-win". Professor Yi Junlin, Director of the Radiotherapy Department at the Cancer Hospital of the Chinese Academy of Medical Sciences, stated that radiation oncology, as the core pillar of cancer treatment, is at a critical juncture of deep integration between technological innovation and clinical practice. This conference has established a top-notch academic exchange platform, greatly promoting the transformation and application of scientific research achievements. Looking ahead to the future, the deep integration of precision medicine and immunotherapy will lead the radiotherapy industry to new heights, continuously improving the treatment effectiveness and quality of life of cancer patients. The conference content is compact and substantial, covering multiple key areas such as radiation therapy technology innovation, advances in immunotherapy, and precision radiation therapy strategies. Professor Jonathan Kniesey from Weill Cornell Medical School in the United States explains in detail the process of transforming scientific research achievements, inspiring researchers to efficiently implement innovative ideas; Academician Yu Jinming from Shandong Cancer Hospital comprehensively analyzed the breakthroughs and clinical applications of modern radiation therapy technology. In terms of basic research, experts have brought innovative perspectives on topics such as ncRNA regulation, liquid-liquid phase separation and radiation-induced DNA damage repair, immune regulated radiotherapy, etc., to promote scientific understanding of precision radiotherapy mechanisms. The clinical treatment topics covered the latest progress in radiotherapy for breast cancer, rectal cancer, liver cancer and pancreatic cancer, and experts shared the cutting-edge achievements, striving to promote the continuous optimization and upgrading of treatment plans. (New Society)